Visit FFF Booth #66 at PPO
Please join the FFF team at the Pharmacy Purchasing Outlook 2007 Conference in Las Vegas.
The August 13 – 16 meeting, once again at the Orleans Hotel, is a great opportunity for pharmacy buyers to meet with their local FFF reps and catch up on marketplace news, including the newest products (see HepaGam B announcement below).
FFF will be in Booth #66, and we’d love to see you. While you’re there, take a moment to learn about FFF’s MyFluVaccine.com, the only U.S. influenza vaccine ordering system that allows you to secure your delivery dates!
Cangene's HepaGam B Available Directly from
FFF Enterprises
FFF Enterprises is pleased to announce that we now carry HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients. Recently approved by the FDA and manufactured by the Canadian-based company, Cangene Corporation, HepaGam B is the first immune globulin product of its kind. "This approval provides a new treatment option for the reduction of hepatitis B recurrence in liver transplant patients with a prior history of this serious disease," said Jesse Goodman, M.D., M.P.H., director of FDA's Center for Biologics Evaluation and Research.
As always, FFF’s Guaranteed Channel Integrity provides a secure supply that ensures biopharmaceuticals move only from the manufacturer to FFF to the healthcare provider. |
